PeerView Oncology CME/CNE/CPE Audio Podcast
Summary: PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
- Visit Website
- RSS
- Artist: PVI, PeerView Institute for Medical Education
- Copyright: 2007
Podcasts:
Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.
Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.
Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.
Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.
Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.
In this activity, an expert in non–small-cell lung cancer (NSCLC) discusses the rationale for studying maintenance therapy in NSCLC settings and the clinical implications of new data on the maintenance use of active cytotoxic agents and targeted therapy in patients with advanced NSCLC.
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.
In this activity, experts provide recommendations for management of disease- and treatment-related complications in multiple myeloma. In the 3 presentations, issues related to thrombosis, neuropathy, and myeloma bone disease are discussed.
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.
In this activity, experts discuss the latest clinical trial data on the use of maintenance therapy, the clinical role of biomarkers in selecting the most appropriate therapy, and the potential of novel agents and combination strategies for advanced lung cancer.